New patent for Janssen Pharms drug XARELTO

Annual Drug Patent Expirations for XARELTO Xarelto is a drug marketed by Janssen Pharms and is included in two NDAs. It is available from four suppliers. There are five patents…

Source


Comments are closed.

Biotechblog